Bionano Genomics Cash from Financing (Quarterly) Insights

Bionano Genomics Inc (BNGO)

0.2505 -0.01 (-2.11%) USD | NASDAQ | Nov 15, 09:38

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
June 30, 2024	-1.978M
March 31, 2024	-21.62M
December 31, 2023	68.48M
September 30, 2023	12.59M
June 30, 2023	17.88M
March 31, 2023	14.86M
December 31, 2022	0.146M
September 30, 2022	22.65M
June 30, 2022	0.203M
March 31, 2022	0.007M
December 31, 2021	1.967M
September 30, 2021	13.77M
June 30, 2021	-17.16M
March 31, 2021	337.54M
December 31, 2020	31.69M

Date	Value
September 30, 2020	15.08M
June 30, 2020	16.27M
March 31, 2020	-1.135M
December 31, 2019	18.49M
September 30, 2019	0.218M
June 30, 2019	0.811M
March 31, 2019	10.86M
December 31, 2018	-0.0323M
September 30, 2018	19.26M
June 30, 2018	3.216M
March 31, 2018	13.33M
December 31, 2017	1.475M
September 30, 2017	2.901M
June 30, 2017	6.257M
March 31, 2017	6.975M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-21.62M

Minimum

Mar 2024

337.54M

Maximum

Mar 2021

27.88M

Average

13.77M

Median

Sep 2021

Cash from Financing (Quarterly) Benchmarks

Revvity Inc	-873.74M
Bruker Corp	-2.70M
Azenta Inc	-224.44M
Harvard Bioscience Inc	2.104M
Akoya Biosciences Inc	-2.125M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-20.98M
Cash from Investing (Quarterly)	28.63M
Free Cash Flow	-106.10M
Free Cash Flow Per Share (Quarterly)	-3.115
Free Cash Flow to Equity (Quarterly)	-11.33M
Free Cash Flow to Firm (Quarterly)	-21.06M
Free Cash Flow Yield	-1.26K%